Programma

News

October 27, 2016

Checking patients progress using an app-based program at Saint Peter’s

Saint Peter’s Healthcare System in New Brunswick, New Jersey will create an app using SeamlessMD, a company that has developed an engagement tool for surgery patients.

Share this article

Saint Peter’s will create an app-based ERAS (enhanced recovery after surgery) program for its caesarean section patients. In the near future the app-based program will also be able to be used by patients recovering from major colon surgery, gynaecologic surgery and other major surgeries.

“When we decided to implement ERAS at our healthcare system, we wanted to do more than just implement the protocols,” said Dr. Attila Kett, medical director of obstetrical anesthesia at Saint Peter’s, said in a statement. “We needed a way to effectively educate our patients, measure their compliance and continuously improve our program over time. We chose SeamlessMD because of its terrific patient experience, the robustness of the platform and the clinical research supporting their system for ERAS.”

Interactive reminders

The engagement program SeamlessMD created is available on tablet, smartphone, and desktop. This program helps patients and providers track a patient’s progress from before their operation to post-op. Before a surgical procedure, SeamlessMD’s tool provides patients with interactive reminders and checklists so that they will stick to the pre-operation instructions.

When the surgery is complete, the app offers digital check-ins, self-management tools, and educational materials. The patient’s progress can be tracked by providers. It can be used for hip and knee replacement, bariatric, colon, thoracic, cardiac, and other high risk surgeries.

“SeamlessMD is honoured to support Saint Peter’s and their mission to deliver the best care possible for their patients,” Dr. Joshua Liu, CEO of SeamlessMD, said in a statement. “We are excited to help Saint Peter’s partner with their patients on the road to recovery.”

Share this article

Don't miss the most exciting developments